Mountain Valley MD Holdings Past Earnings Performance
Past criteria checks 0/6
Mountain Valley MD Holdings has been growing earnings at an average annual rate of 17.8%, while the Pharmaceuticals industry saw earnings growing at 51% annually. Revenues have been growing at an average rate of 48.9% per year.
Key information
17.8%
Earnings growth rate
31.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 48.9% |
| Return on equity | -71.6% |
| Net Margin | -12,361.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Mountain Valley MD Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -7 | 3 | 1 |
| 30 Sep 23 | 0 | -4 | 3 | 1 |
| 30 Jun 23 | 0 | -6 | 3 | 1 |
| 31 Mar 23 | 0 | -7 | 4 | 1 |
| 31 Dec 22 | 0 | -7 | 4 | 2 |
| 30 Sep 22 | 0 | -9 | 6 | 2 |
| 30 Jun 22 | 0 | -9 | 7 | 2 |
| 31 Mar 22 | 0 | -10 | 7 | 2 |
| 31 Dec 21 | 0 | -14 | 8 | 3 |
| 30 Sep 21 | 0 | -12 | 6 | 2 |
| 30 Jun 21 | 0 | -10 | 4 | 2 |
| 31 Mar 21 | 0 | -8 | 3 | 1 |
| 31 Dec 20 | 0 | -20 | 3 | 0 |
| 30 Sep 20 | 0 | -19 | 3 | 0 |
| 30 Jun 20 | 0 | -19 | 3 | 0 |
| 31 Mar 20 | 0 | -19 | 3 | 0 |
Quality Earnings: MVMD is currently unprofitable.
Growing Profit Margin: MVMD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MVMD is unprofitable, but has reduced losses over the past 5 years at a rate of 17.8% per year.
Accelerating Growth: Unable to compare MVMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MVMD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (39.8%).
Return on Equity
High ROE: MVMD has a negative Return on Equity (-71.63%), as it is currently unprofitable.